Enliven Therapeutics, Inc. SEC filings ELVN
Enliven Therapeutics, Inc. has 798 filings in SEC EDGAR's recent list, going back to Apr 21, 2016. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jun 12, 2026 | — |
| 424B5 | Prospectus supplement | Jun 11, 2026 | — |
| S-8 | Employee stock plan registration | Mar 3, 2026 | — |
| S-8 | Employee stock plan registration | Dec 16, 2025 | — |
| S-3ASR | Automatic shelf registration | Aug 13, 2025 | — |
| 424B5 | Prospectus supplement | Jun 16, 2025 | — |
| S-3MEF | Filing | Jun 13, 2025 | — |
| 424B5 | Prospectus supplement | Jun 13, 2025 | — |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| S-8 | Employee stock plan registration | Jun 20, 2024 | — |
| 424B3 | Prospectus | Apr 30, 2024 | — |
| S-3 | Shelf registration | Apr 18, 2024 | — |
| S-8 | Employee stock plan registration | Mar 14, 2024 | — |
| 424B5 | Prospectus supplement | Jul 6, 2023 | — |
| S-3 | Shelf registration | Jun 23, 2023 | — |
| S-8 | Employee stock plan registration | Mar 1, 2023 | — |
| 424B3 | Prospectus | Jan 23, 2023 | — |
| S-4/A | Filing | Jan 9, 2023 | — |
| S-4/A | Filing | Dec 19, 2022 | — |
| S-4 | Registration for a merger or exchange | Nov 10, 2022 | — |
| 424B5 | Prospectus supplement | Mar 15, 2022 | — |
| S-8 | Employee stock plan registration | Mar 15, 2022 | — |
| S-8 | Employee stock plan registration | Aug 6, 2021 | — |
| 424B5 | Prospectus supplement | Jul 14, 2021 | — |
| 424B5 | Prospectus supplement | Jul 13, 2021 | — |
| S-3 | Shelf registration | Apr 1, 2021 | — |
| S-8 | Employee stock plan registration | Mar 12, 2020 | — |
| 424B4 | Prospectus | Mar 12, 2020 | — |
| S-1/A | Amended registration statement | Mar 10, 2020 | — |
| S-1/A | Amended registration statement | Mar 3, 2020 | — |
| S-1 | Registration statement | Feb 14, 2020 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELVN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Burlingame, CA
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1672619
- Former names
- IMARA Inc. (until Feb 23, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.